Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: A 10-year follow-up study of 118 patients

Haematologica

Volumn 90, Issue 1, 2005, Pages 139-140

  Isidori, Alessandro ^a   Bonifazi, Francesca ^a   Visani, Giuseppe ^b   Gherlinzoni, Filippo ^c   Baccarani, Michele ^a   Lemoli, Roberto Massimo ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c CA FONCELLO HOSPITAL   (Italy)

^d Institute of Hematology and Medical Oncology Seragnoli   (Italy)

Author keywords

AML; Autologous stem cell transplantation; CR 1; Cytogenetics

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REMISSION; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 13244261079     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Zittoun RA, Mandelli F, Willemze R, de Wittw T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995;332:217-23.
2. Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998;339:1649-56.
3. Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees JK, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet 1998;351:700-8.
4. Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, et al. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia: analysis of 848 patients. Leukemia 2001;15:903-9.
5. Miggiano MC, Gherlinzoni F, Rosti G, Bandini G, Visani G, Fiacchini M, et al. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. Leukemia 1996;10:402-9.
6. Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P, et al. Use of pheripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Bone Marrow Transplant 1999;24:467-72.
7. Visani G, Lemoli RM, Isidori A, Piccaluga PP, Martinelli G, Malagola M, et al. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem Cell transplantation in acute myeloid leukemia patients. Bone Marrow transplant 2001;27:829-35.
8. Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini G, et al. Autologous transplntation of granulocyte colony-stimulating factor-primed bone marrow is effective to support myeloablative chemotherapy in patients with hematological malignancies and poor peripheral blood stem cell mobilization. Blood 2003;102:1595-600.